High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: A short-term animal model of diabetic retinopathy

British Journal of Pharmacology

Volumn 173, Issue 1, 2016, Pages 15-26

  Jung, Seung Hyun ^a   Kim, Young Sook ^a   Lee, Yu Ri ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN ZO1; RANIBIZUMAB; VASCULOTROPIN; TIGHT JUNCTION PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGF PROTEIN, ZEBRAFISH; ZEBRAFISH PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EMBRYO; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOMICROSCOPY; TRANSGENIC ZEBRAFISH; VASCULOTROPIN GENE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LARVA; METABOLISM; PATHOLOGY; TRANSGENIC ANIMAL; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; GLUCOSE; LARVA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RANIBIZUMAB; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL VESSELS; TIGHT JUNCTION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84952636489     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13279     Document Type: Article

References (51)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. Br J Pharmacol 170: 1676-1705.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Alvarez Y, Cederlund ML, Cottell DC, Bill BR, Ekker SC, Torres-Vazquez J, et al., (2007). Genetic determinants of hyaloid and retinal vasculature in zebrafish. BMC Dev Biol 7: 114-130.
4. Alvarez Y, Chen K, Reynolds AL, Waghorne N, O'Connor JJ, Kennedy BN, (2010). Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Dis Model Mech 3: 236-245.
5. Abu El-Asrar AM, Meersschaert A, Dralands L, Geboes K, (2004). Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18: 306-313.
6. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW, (1998). Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Res Group Diab 47: 1953-1959.
7. Armulik A, Abramsson A, Betsholtz C, (2005). Endothelial/pericyte interactions. Circ Res 97: 512-523.
8. Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S, (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 154: 1400-1413.
9. Bergers G, Song S, (2005). The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464.
10. Calcutt NA, Cooper ME, Kern TS, Schmidt AM, (2009). Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 8: 417-429.
11. Caldwell RB, Bartoli M, Behzadian MA, EI-Remessy AE, AI-Shabrawey M, Platt DH, et al., (2003). Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19: 442-455.
12. Cao Z, Jensen LD, Rouhi P, Hosaka K, Lanne T, Steffensen JF, et al., (2010). Hypoxia-induced retinopathy model in adult zebrafish. Nat Protoc 5: 1903-1910.
13. Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S, (2006). Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci 47: 3595-3602.
14. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, et al., (2005). Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54: 3119-3125.
15. Elo B, Villano CM, Govorko D, White LA, (2007). Larval zebrafish as a model for glucose metabolism: expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds. J Mol Endocrinol 38: 433-440.
16. Engerman RL, Kern TS, (1995). Retinopathy in animal models of diabetes. Diabetes Metab Rev 11: 109-120.
17. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, et al., (2005). Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46: 4281-4287.
18. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al., (2003). Diabetic retinopathy. Diabetes Care 26: 226-229.
19. Francesco C, Keiichi H, Zvonimir SK, Thomas FL, (1997). High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28.
20. Geoffrey BA, Sobha S, (2011). Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7: 291-304.
21. Gleeson M, Connaughton V, Arneson LS, (2007). Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol 44: 157-163.
22. Greene DA, Arezzo JC, Brown MB, (1999). Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 53: 580-591.
23. Guillemin GJ, Brew BJ, (2004). Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 75: 388-397.
24. Jorgens K, Hillebrands JL, Hammes HP, Kroll J, (2012). Zebrafish: a model for understanding diabetic complications. Exp Clin Endocrinol Diabetes 120: 186-187.
25. Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, et al., (2002). Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 2: 501-509.
26. Jung SH, Kim S, Chung AY, Kim HT, So JH, Ryu J, et al., (2010). Visualization of myelination in GFP-transgenic zebrafish. Dev Dyn 2: 592-597.
27. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al., (2004). The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552-563.
28. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: The ARRIVE guidlines. Br J Pharmacol 160: 1577-1579.
29. Kim JH, Yu YS, Kim KW, Kim JH, (2011). Investigation of barrier characteristics in the hyaloid-retinal vessel of zebrafish. J Neurosci Res 89: 921-928.
30. Kitambi SS, McCulloch KJ, Peterson RT, Malicki JJ, (2009). Small molecule screen for compounds that affect vascular development in the zebrafish retina. Mech Dev 126: 464-477.
31. Lakshminarayanan S, Antonetti DA, Gardner TW, Tarbell JM, (2000). Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO. Invest Ophthalmol Vis Sci 41: 4256-4261.
32. Lee IS, Yu SY, Jung SH, Lee YR, Lee YM, Kim JH, et al., (2013). Proanthocyanidins from Spenceria ramalana and their effects on AGE formation in vitro and hyaloid-retinal vessel dilation in larval zebrafish in vivo. J Nat Prod 76: 1881-1888.
33. Lepiller S, Laurens V, Bouchot A, Herbomel P, Solary E, Chluba J, (2007). Imaging of nitric oxide in a living vertebrate using a diamino-fluorescein probe. Free Radic Biol Med 43: 619-627.
34. Liang J, Gui Y, Wang W, Gao S, Li J, Song H, (2010). Elevated glucose induces congenital heart defects by altering the expression of tbx5, tbx20, and has2 in developing zebrafish embryos. Birth Defects Res A Clin Mol Teratol 88: 480-486.
35. McGrath JC, Drummond GB, McLachlan EM, KilKenny C, Wainwright CL, (2010). Guidelins for reporteing experiments involving animals: the ARRIVE guidlines. Br J Pharmacol 160: 1573-1576.
36. Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, et al., (1989). Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 21: 106-111.
37. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M, (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary vascular endothelium. Am J Physiol 270: H411-415.
38. Nusslein VC, Dahm R, (eds) (2002). Zebrafish: A Practical Approach. Oxford University Press: Oxford, UK.
39. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1106.
40. Pfister F, Feng Y, vom Hagen F, Hoffmann S, Molema G, Hillebrands JL, et al., (2008). Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 57: 2495-2502.
41. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS, (2012). Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 5: 444-456.
42. Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH, (2004). The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 122: 546-551.
43. Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, et al., (2008). Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest 118: 2337-2346.
44. Sheetz MJ, King GL, (2002). Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588.
45. δ activity. Circ Res 85: 247-256.
46. Starita C, Patel M, Katz B, Adamis AP, (2007). Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy. Dev Ophthalmol 39: 122-148.
47. Van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, LeKutat C, et al., (1997). Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95: 1030-1037.
48. Wang Z, Mao Y, Cui T, Tang D, Wang XL, (2013). Impact of a combined high cholesterol diet and high glucose environment on vasculature. PLoS One 12: e81485.
49. Wu YC, Chang CY, Kao A, Hsi B, Lee SH, Chen YH, et al., (2015). Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity. PLoS One 15: e0126750.
50. Yu SY, Lee IS, Jung SH, Lee YM, Lee YR, Kim JH, et al., (2013). Caffeoylated phenylpropanoid glycosides from Brandisia hancei inhibit advanced glycation end product formation and aldose reductase in vitro and vessel dilation in larval zebrafish in vivo. Planta Med 79: 1705-1709.
51. Zhang H, Sonoda KH, Qiao H, Oshima T, Hisatomi T, Ishibashi T, (2007). Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. Jpn J Ophthalmol 51: 251-257.